This new report from Venture Planning Group contains 521 pages, 63 tables, and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including:
Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian hospitals, including controls, calibrators and consumables.
Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
Review of current instrumentation technologies, and a feature comparison
of high-, medium-, and low-volume/POC analyzers.
Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 521 pages and 63 tables